2021 annual financial data
Xeris Biopharma Holdings 2021 Operating margin
Direct answer
Operating margin was -232.22%.
Operating income was -115,156,000 USD and net income was -122,725,000 USD.
Operating cash flow was -95,535,000 USD.
Get free Xeris Biopharma Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 49,590,000 USD
- Operating income
- -115,156,000 USD
- Net income
- -122,725,000 USD
- Operating cash flow
- -95,535,000 USD